Neal D. Shore, MD, highlights emerging therapies in prostate cancer such as radium-223, ipilimumab, PROSTVAC, custirsen, and tasquinimod.
For more from this conversation: onclive.com/peer-exchange/prostate-cancer-management
- Dr. Shore Reviews Emerging Therapies in Prostate Cancer ( Download)
- Dr. Shore on the Management of Patients with Advanced Prostate Cancer ( Download)
- Dr. Shore on Genomic Assays in Prostate Cancer ( Download)
- Dr. Shore on Therapy Combination and Sequencing in Castration-Resistant Prostate Cancer ( Download)
- Dr. Shore on the Objective of the HERO Trial in Advanced Prostate Cancer ( Download)
- Dr. Shore on Cardio-Oncology Strategies in Prostate Cancer ( Download)
- New drug gives hope to prostate cancer patients ( Download)
- Reimbursement and Operational Issues in the Treatment of Prostate Cancer, Part I ( Download)
- Dr. Shore on the Enzalutamide Mechanism of Action ( Download)
- Dr Neal Shore talks to us from ASCO 2015 ( Download)
- Immunotherapy for Advanced Prostate Cancer with Neal Shore, MD- EP 103 ( Download)
- Dr. Raoul Concepcion Discusses New Prostate Cancer Therapies ( Download)
- Future Directions in Treating Advanced Prostate Cancer ( Download)
- Phase 3 trial results suggest potential new treatment approach for prostate cancer ( Download)
- New prostate cancer treatment available in south Florida hospital ( Download)
